QT Imaging Holdings Inc (NAS:QTI)
$ 2.7 -0.18 (-6.25%) Market Cap: 39.52 Mil Enterprise Value: 44.32 Mil PE Ratio: 0 PB Ratio: 16.88 GF Score: 6/100

Q2 2026 QT Imaging Holdings Inc Earnings Call Transcript

Aug 12, 2026 / 08:30 PM GMT
Release Date Price: $3.01 (+4.15%)

Key Points

Positve
  • QT Imaging Holdings Inc (QTI) reported a 103% year-over-year revenue increase in Q2 2026, reaching $7.4 million, driven by the shipment of 15 scanners.
  • The company received FDA clearance for an enhanced scanner configuration and software functionality, expanding the platform's capabilities.
  • QT Imaging Holdings Inc (QTI) secured a dedicated Category 3 CPT reimbursement code from the AMA, effective January 1, 2027, which creates a framework for future coverage decisions.
  • The company strengthened its balance sheet with a $10 million underwritten public offering and extended its senior secured term loan maturity by two years.
  • QT Imaging Holdings Inc (QTI) successfully completed its first routine FDA inspection with zero Form 483 observations, reflecting strong quality management systems.
  • The company expanded its international regulatory footprint with clearances from the Saudi Food and Drug Authority and the Ministry of Health in Israel.
  • QT Imaging Holdings Inc (QTI) is advancing multiple clinical studies, including a Mayo Clinic study and a high-risk population study in Israel, to build clinical evidence.
  • The company is relocating to a new 22,000 square foot facility in Petaluma, California, which will more than double operational space while reducing lease cost per square foot by approximately 55%.
Negative
  • QT Imaging Holdings Inc (QTI)'s gross margin declined to 41% in Q2 2026 from 50% in the prior year quarter, due to a lower weighted average cost of inventory sold in the prior period.
  • The company reported a net loss of $11.1 million in Q2 2026, significantly wider than the $4.0 million loss in Q2 2025, partly due to an $8.3 million non-cash loss on debt extinguishment and modification.
  • QT Imaging Holdings Inc (QTI) increased its interest rate on the senior secured term loan from 10% to 12% per annum as part of the maturity extension.
  • The company acknowledged that geopolitical developments have impacted commercial activity in parts of the Gulf region, affecting sales momentum.
  • QT Imaging Holdings Inc (QTI) noted that scanner implementation and customer adoption is progressing slower than desired, requiring additional support from its direct sales team.
  • Operating expenses increased to $4.9 million in Q2 2026 from $2.9 million a year ago, reflecting higher compensation, professional services, and marketing costs.
  • The company's 2026 revenue guidance of approximately $39 million relies on distributor minimum order quantities and direct sales contributions, which may be subject to execution risks.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

QTI.OQ - QT Imaging Holdings Inc
Q2 2026 QT Imaging Holdings Inc Earnings Call
Aug 12, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you. This is Turf Patel with Core IR.

Thank you for participating in today's call. Join Imaging are Dr. Waluka Dinu, Chief Executive Officer and Jay Jennings, Chief Financial Officer.

I want to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. Any statements that are not statements of historical facts should be deemed to be forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements.

All forward-looking statements are
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot